25T-57707-76575
3 vaccinations
1 coded response
33 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 212 / MD
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Registered in v-safe
-
2021-04-09
Dose 1 — Pfizer-BioNTech
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-23
- 2021-04-30
-
2021-05-01
Dose 2 — Pfizer-BioNTech
- 2021-05-07
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-06-05
- 2021-06-13
- 2021-07-31
- 2021-10-30
-
2022-01-03
Dose 3 — Moderna
- 2022-01-05
- 2022-01-06
- 2022-01-07
- 2022-01-08
- 2022-01-09
- 2022-01-10
- 2022-01-17
- 2022-01-26
- 2022-01-31
- 2022-02-07
- 2022-02-14
- 2022-04-04
- 2022-07-06
-
2023-01-04
Survey response — 12 months, dose 3MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-05-01 | Pfizer-BioNTech | |
| 3 | 2022-01-03 | Moderna | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release